Evidence map›Paper›PMID 37199072›Full record

ArticleCell proliferation2023

Cell spheroids culture array with modifiable chemical gradients.

Panhui Yang, Lei Wu, Guoyuan Zhang, Yuqing Ge, Ting Liu, Hongju Mao, Jianlong Zhao

Abstract read
In one paragraph

Article in Cell proliferation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Panhui YangShanghai Institute of Microsystem and Information Technology, CAS, Shanghai, China.ORCID https://orcid.org/0000-0003-0465-3490
Lei WuShanghai Institute of Microsystem and Information Technology, CAS, Shanghai, China.
Guoyuan ZhangShanghai Institute of Microsystem and Information Technology, CAS, Shanghai, China.
Yuqing GeShanghai Institute of Microsystem and Information Technology, CAS, Shanghai, China.
Ting LiuShanghai Institute of Microsystem and Information Technology, CAS, Shanghai, China.
Hongju MaoShanghai Institute of Microsystem and Information Technology, CAS, Shanghai, China.
Jianlong ZhaoShanghai Institute of Microsystem and Information Technology, CAS, Shanghai, China.ORCID https://orcid.org/0000-0001-6374-5868

Funding

The National Key R&D Program of China 2022YFA1104700The Strategic Priority Research Program of the Chinese Academy of Sciences XDA16021200
6 · The paper itself

Abstract

Cancer cell spheroids have been shown to mimic in vivo tumour microenvironment and are therefore suitable for in vitro drug screening. Microfluidic technology can provide conveniences for spheroid assays such as high-throughput, simplifying manual operation and saving reagent. Here, we propose a concentration gradient generator based on microfluidic technology for cell spheroid culture and assay. The chip consists of upper microchannels and lower microwells. After partitioning HepG2 suspension into the microwells with concave and non-adhesive bottoms, spheroids can spontaneously form. By controlling the fluid replacement and flow in microchannels, the doxorubicin solution is diluted automatically into a series of concentration gradients, which spanning more than one order of magnitude. And then the effect of doxorubicin on spheroids is measured in situ by fluorescent staining. This chip provides a very promising approach to achieve the high-throughput and standardized anti-cancer drug screening in future.

Indexed as

Antineoplastic AgentsSpheroids, CellularCell Culture TechniquesDoxorubicinDrug Evaluation, PreclinicalAntineoplastic AgentsDoxorubicin

Identifiers

PMID37199072
PMCPMC10212701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.